MultiPoint Pacing IDE Study

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 506 participants.

Also called NCT01786993

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 506 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01786993
Other papers using this trial's data
  • Safety and Efficacy of Multipoint Pacing in Cardiac Resynchronization Therapy: The MultiPoint Pacing Trial JACC. Clinical electrophysiology, 2017-12-26 DOI, PubMed 29759832

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01786993. Randomized; double masking; primary purpose treatment. Start 2013-04 (actual); primary completion 2015-04 (actual). Results posted on 2016-09-30.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
MultiPoint Pacing IDE Study
Acronym
MPP IDE
Condition
Heart Failure
Intervention (Device)
MultiPoint Pacing
Intervention (Device)
Traditional Biventricular Pacing
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct01786993
Content hash
3c80b498ce04813cf2ee1701aab9322f288acbb32eb42e6919c437d9db4d106e